Tower Transplant Teams ‘Transition’ to Penn Medicine

WEST READING PA – Struggling Tower Health, which just last month said it would pursue a “strategic alliance” with Philadelphia-based Penn Medicine as a way to remain independent while working to improve its finances, said Wednesday (Aug. 25, 2021) its regional transplant center at Reading Hospital “will transition to” Penn by mid-December.

The two healthcare systems anticipate a “careful integration” of Tower Health’s Transplant Institute and related transplant nephrology and hepatology practices to the Penn Transplant Institute at the Hospital of the University of Pennsylvania. The reason: “Long-term costs associated with growing the (Tower) program were not sustainable,” Tower Health President and CEO P. Sue Perrotty acknowledged.

Penn Medicine will establish a regional transplant program at Reading Hospital to provide patient screening and pre- and post-transplant kidney and liver care within central Pennsylvania, Tower said in a media release. The Tower institute staff and programs otherwise will become part of the Penn Transplant Institute operating out of Center City.

Transplant patients will be provided information about the Penn Transplant Institute, as well as other regional transplant programs throughout the region.

Penn’s institute, founded in 1966, currently is one of the most active solid organ transplant programs in the country, the release said. The transition does not include the long-standing pediatric kidney transplant service provided by St. Christopher’s Hospital for Children, which will continue at St. Christopher’s.

Photo by Mehmet Turgut Kirkgoz via Unsplash, used under license